Legal Representation
Attorney
Michelle Rosenberg
USPTO Deadlines
Next Deadline
121 days remaining
NOA E-Mailed - SOU Required
Due Date
May 25, 2026
Extension Available
Until November 25, 2026
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 25, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 30, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 30, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 24, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 1, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 31, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 22, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 22, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 22, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, Lewy body dementia, and Alzheimer’s disease
Classification
International Classes
005